The Relative Strength (RS) Rating for Balchem headed into a higher percentile Tuesday, as it got a lift from 68 to 73.
This proprietary rating tracks market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the trailing 52 weeks compares to other publicly traded companies.
History reveals that the stocks that go on to make the biggest gains often have an RS Rating of at least 80 as they launch their biggest climbs. See if Balchem can continue to show renewed price strength and hit that benchmark.
Can You Really Time The Stock Market?
Balchem is not currently offering a proper buying opportunity. See if the stock goes on to build a chart pattern that could spark a new run.
Taking a look at top and bottom line numbers, the company has posted two quarters of rising earnings growth. Revenue growth has also moved higher during the same period. Balchem is expected to report its next quarterly numbers on or around Apr. 25.
Balchem earns the No. 3 rank among its peers in the Chemicals-Specialty industry group. NewMarket is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
